Your Input is Requested: AQCG Survey on OOS Investigations
Recommendation

Tuesday, 10 November 2026 9 .00 - 17.00 h
The ECA Analytical Quality Control Group (AQCG) is currently revising and updating its guidance on Out-of-Specification (OOS) results. The goal is to better reflect current industry practices and to provide clear, practical recommendations that are aligned with today’s regulatory expectations.
To support this important activity, AQCG has launched a member survey focusing on how OOS investigations are defined, structured, and performed across the industry. The questionnaire addresses key aspects such as internal SOPs, investigation phases, testing and retesting strategies, hypothesis testing, decision-making processes, and the handling of confirmed or inconclusive OOS results.
All responses will be evaluated in an aggregated and fully anonymized manner. None of the questions are mandatory, and participants may skip any questions they prefer not to answer. At the end of the survey, respondents are also invited to propose additional topics or questions that AQCG should consider in future guidance documents.
Thank you for your valuable time and support.
Related GMP News
02.11.2026FDA Warning Letter: When Test Procedures Allow Retesting Until an Acceptable Result is Obtained
21.10.2026EMA Updates Information Page on Bioequivalence Guidelines
21.10.2026BP Publishes new Draft Texts
21.10.2026FDA Identifies Critical Deficiencies in Analytical Testing and CGMP Oversight
07.10.2026Analytical Quality Group Developments May through August 2026
07.10.2026Two New FDA Warning Letters Put OOS Investigations in Focus


